Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
NCT06629363
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Malignant Hypertension
Interventions
OTHER:
biobank
Sponsor
Centre Hospitalier de PAU